Dasiglucagon Hydrochloride

CHEMBL4650274 Phase 4 Approuvé Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A hydrochloride salt of dasiglucagon, a stable liquid glucagon analog used to treat severe hypoglycemia (dangerously low blood sugar) in patients with diabetes. It works by stimulating the liver to release stored glucose into the bloodstream.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A hydrochloride salt of dasiglucagon, a stable liquid glucagon analog used to treat severe hypoglycemia (dangerously low blood sugar) in patients with diabetes. It works by stimulating the liver to release stored glucose into the bloodstream.

Yes, Dasiglucagon Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4650274. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Dasiglucagon Hydrochloride sur PillFYI

Données Clés

Liens externes

ChEMBL CHEMBL4650274

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.